The DOI matches its Crossref record; 56 of the 57 references it cites were found in a registry or an index.
Interleukin 6 receptor antibody inhibits muscle atrophy and modulates proteolytic systems in interleukin 6 transgenic mice.
Open accessAbstract
The muscles of IL-6 transgenic mice suffer from atrophy. Experiments were carried out on these transgenic mice to elucidate activation of proteolytic systems in the gastrocnemius muscles and blockage of this activation by treatment with the anti-mouse IL-6 receptor (mIL-6R) antibody. Muscle atrophy observed in 16-wk-old transgenic mice was completely blocked by treatment with the mIL-6R antibody. In association with muscle atrophy, enzymatic activities and mRNA levels of cathepsins (B and L) and mRNA levels of ubiquitins (poly- and mono-ubiquitins) increased, whereas the mRNA level of muscle-specific calpain (calpain 3) decreased. All these changes were completely eliminated by treatment with the mIL-6R antibody. This IL-6 receptor antibody could, therefore, be effective against muscle wasting in sepsis and cancer cachexia, where IL-6 plays an important role.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“the pilot study of Tsujinaka and colleagues showed that transgenic mice chronically overexpressing IL-6 exhibit a marked muscle atrophy [47]; however, the knockout of IL-6 was not sufficient to prevent sarcopenia in a sepsis mouse model [48].”
From Main Pathogenic Mechanisms and Recent Advances in COPD Peripheral Skeletal Muscle Wasting (2023) · cites this paper as [47]
In the citing paper
“However, it has also been shown that proinflammatory cytokines may inhibit muscle progenitor cell differentiation and that the reactive oxygen species that are produced by M1 cells (nitric oxide) can be cytotoxic if present in sufficient quantities, demonstrating the need for resolution of the proinflammatory response for muscle recovery to proceed beyond this initial stage [120–122].”
From Macrophage polarization: an opportunity for improved outcomes in biomaterials and regenerative medicine (2012) · cites this paper as [122]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bradford, M. M. (1976) · Analytical Biochemistry · doi:10.1016/0003-2697(76)90527-3 · Cited by 255,302
Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease
Chirgwin, J. M., Przybyla, A., MacDonald, R. J., & Rutter, W. J. (1979) · Biochemistry · doi:10.1021/bi00591a005 · Cited by 21,460
[41] Cathepsin B, cathepsin H, and cathepsin L
Barrett, A. J., & Kirschke, H. (1981) · Methods in Enzymology · doi:10.1016/s0076-6879(81)80043-2 · Cited by 1,698
THE UBIQUITIN SYSTEM FOR PROTEIN DEGRADATION
Hershko, A., & Ciechanover, A. J. (1992) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.61.070192.003553 · Cited by 1,448
Mutations in the proteolytic enzyme calpain 3 cause limb-girdle muscular dystrophy type 2A
Richard, I., Broux, O., Allamand, V., Fougerousse, F., Chiannilkulchai, N., Bourg, N., Brenguier, L., Devaud, C., Pasturaud, P., Roudaut, C., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90368-2 · Cited by 998
Soluble interleukin-6 receptor triggers osteoclast formation by interleukin 6.
Tamura, T., Udagawa, N., Takahashi, N., Miyaura, C., Tanaka, S., Yamada, Y., Koishihara, Y., Ohsugi, Y., Kumaki, K., & Taga, T. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.24.11924 · Cited by 828
Self-citationEvidence for the involvement of interleukin 6 in experimental cancer cachexia.
Strassmann, G., Fong, M., Kenney, J. S., & Jacob, C. O. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115767 · Cited by 660
IgG1 plasmacytosis in interleukin 6 transgenic mice
Suematsu, S., Matsuda, T., Aozasa, K., Akira, S., Nakano, N., Ohno, S., Miyazaki, J., Yamamura, K., Hirano, T., & Kishimoto, T. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.19.7547 · Cited by 586
Mitch, W. E., Medina, R., Grieber, S., May, R. C., England, B. K., Price, S. R., Bailey, J. L., & Goldberg, A. L. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117208 · Cited by 405
Molecular cloning of a novel mammalian calcium-dependent protease distinct from both m- and μ-types
Sorimachi, H., Imajoh‐Ohmi, S., Emori, Y., Kawasaki, H., Ohno, S., Minami, Y., & Suzuki, K. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)47225-6 · Cited by 381
Self-citation
Cited by
Sorted by citations
Items 401–420 of 420
Humoral immune responses in different stages of wound healing in Black Bengal goats
Samaddar, K., Rahman, M. H., Leon, M. L. I., Rana, M. S., Hasan, M. M., Haque, Z., & Rahman, M. M. (2023) · Journal of Advanced Veterinary and Animal Research · doi:10.5455/javar.2023.j688
Li, N., Ren, Y., Qi, F., Li, J., Xinyue, L., Liu, H., Wang, Y., Wang, G., Yuanting, Z., & Yaoyang, S. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.5049431
The Molecular Mechanisms and Treatment of Cancer-Related Cachexia
Yongfei, Y. O. U., Yong, W. A. N. G., Zhang, G., & Li, Y. (2025) · Journal of Nutritional Science and Vitaminology · doi:10.3177/jnsv.71.1 · Cited by 1
Adipositas im Alter – Auswirkungen auf Kraft und -Funktion der Skelettmuskulatur
Mutlu, M., Müller‐Werdan, U., & Norman, K. (2025) · Adipositas - Ursachen Folgeerkrankungen Therapie · doi:10.1055/a-2483-4654
“Adipositasinduzierte Inflammation führt nicht nur zu einer Insulinresistenz, sondern beeinflusst die Muskelprote - insynthese und Regeneration von Muskelgewebe und fördert den Abbau von Muskelproteinen durch hohe Konzentrationen an IL-6 [46, 47] und TNF-alpha [48].”
Tajima, S., Arai, K., Yamakawa, H., & Kanezaki, M. (2025) · ERJ Open Research · doi:10.1183/23120541.00729-2025
Burton, L. A. (2011) · Discovery Research Portal (University of Dundee)
Toussirot, É., Marotte, H., Mulleman, D., Cormier, G., Coury, F., Gaudin, P., Dernis, E., Bonnet, C., Damade, R., Grauer, J.-L., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13023935
Chen, B., Li, S., Lin, S., & Dong, H. (2024) · Figshare · doi:10.6084/m9.figshare.25834254
Chen, B., Li, S., Lin, S., & Dong, H. (2024) · Figshare · doi:10.6084/m9.figshare.26720883
Chen, B., Li, S., Lin, S., & Dong, H. (2024) · Figshare · doi:10.6084/m9.figshare.25834115
Chen, B., Li, S., Lin, S., & Dong, H. (2024) · Figshare · doi:10.6084/m9.figshare.26720886
Shigekusa, T., Tsubouchi, H., Yanagi, S., Sakai, K., Honda, M., Inomata, R., Miyazaki, T., & Nakazato, M. (2026) · Heliyon · doi:10.1016/j.heliyon.2026.e44532
Semel, M. G., Lukasiewicz, C. J., Skinner, S. K., Viggars, M. R., Noh, S. G., Picard, M., Mannings, A.-G., Cohen, M. S., Wolan, D. W., RYAN, T. E., et al. (2026) · The Journal of Physiology · doi:10.1113/jp291213
Beyond muscle weakness: pathogenesis of sepsis-induced myopathy and its management
Liu, Y., Zhao, X., Xu, Z., Liu, Q., & Wang, Y.-C. (2026) · Open Medicine · doi:10.1515/med-2025-1342
“Moreover, IL-6 receptor antibodies pro fi ciently mitigate muscle atrophy in sepsis and cancer cachexia by regulating the proteolytic system [102].”
Role of immune and nervous system interaction : pre-clinical and clinical studies
Daoudlarian, D. (2018) · theses.fr (ABES) · doi:10.70675/77feff3azfefbz422az89bdzeafc45e09199
Regular Daily Exercise Improves Sarcopenia in Elderly Patients
Zheng, J., Luo, H., Zheng, Z., Wang, S., Mo, T., & Ma, Y. (2026) · Rejuvenation Research · doi:10.1177/15491684261449707 · Cited by 1
“7,8 17 Randomized controlled trials have shown that exercise interventions can reduce TNF-a and IL-6 levels while enhancing muscle function.”
Sohail, Z., Hadi, N. B. A., Rehman, A., Asghar, M., & Zaman, F. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1833900
“Upregulation of IL-6 causes body weight reduction, which is independent of caloric intake, while IL-6 blockade attenuates muscle wasting in tumor-bearing models, demonstrating its causal role in catabolic states (230, 233).”
Convergent innate immune and regulated cell-death pathways in selected myopathies
Yamashita, M., Park, J., Park, S., Kang, H. J., Chung, Y., Lim, S. A., & Lee, S. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1871966
“Consistently, IL-6 – de fi cient mice develop myositis with a lower incidence and reduced severity in the C-protein-induced myositis (CIM) model (56), whereas blockade of IL-6 receptor signaling completely prevents muscle atrophy in IL-6 transgenic mice (57).”
Osaki, Y., Kaji, K., Nishimura, N., Iwata, T., Kachi, H., Motokawa, Y., Mori, H., Shibamoto, A., Iwai, S., Tsuji, Y., et al. (2026) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2026.168468
Metadata
- Authors
- Tsujinaka, T., Fujita, J., Ebisui, C., Yano, M., Kominami, E., Suzuki, K., Tanaka, K., Katsume, A., Ohsugi, Y., Shiozaki, H., & Monden, M.
- Affiliations
- Osaka University Hospital (JP)
- The University of Osaka (JP)
- Juntendo University (JP)
- Institute for Quantitative Biosciences, The University of Tokyo (JP)
- Chugai Pharmaceutical Co., Ltd. (Japan) (JP)
- Venue
- Journal of Clinical Investigation
- Published
- 1996-01-01
- Volume
- 97
- Issue
- 1
- Pages
- 244-249
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC507086
- OpenAlex
- W2060757943
- Cited by
- 421
- References
- 57
- Citations by year
- 2026: 10 · 2025: 12 · 2024: 16 · 2023: 10 · 2022: 22 · 2021: 16 · 2020: 13 · 2019: 9 · 2018: 14 · 2017: 11 · 2016: 9 · 2015: 17 · 2014: 9 · 2013: 14 · 2012: 18
- FWCI
- 5.18
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
- Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
- Health Sciences › Nursing › Nutrition and Dietetics › Muscle metabolism and nutrition
- Keywords
- interleukin-6, IL-6 receptor antibody, muscle atrophy, proteolytic system, cathepsin B, cathepsin L, ubiquitin, CAPN3, gastrocnemius, cancer cachexia, sepsis
- MeSH terms
- Animals, Antibodies, Monoclonal, Body Weight, Calpain, Cathepsin B, Cathepsins, Cysteine Endopeptidases, Humans, Mice, Inbred C57BL, Mice, Transgenic, Multienzyme Complexes, Muscular Atrophy, Organ Size, Endopeptidases, RNA, Messenger, Ubiquitins, Antigens, CD, Interleukin-6, Gene Expression, Rats, Wistar, Receptors, Interleukin, Muscle, Skeletal, Receptors, Interleukin-6, Proteasome Endopeptidase Complex, Mice, Rats, Cathepsin L
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
